🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase Ib single-arm, open-label clinical trial determining the fe...
Status
Completed
Location
Chao Family Comprehensive Cancer Center, University of California, Irvine
Start Date
2019-08-26
Trial ID
NCT04074343
Treatments Being Tested
The gold standard treatment for locally advanced, non-metastatic rectal can...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10
Trial ID
NCT06097416
Treatments Being Tested
The treating physician/investigator contacts Lilly when, based on their med...
Status
Approved For Marketing
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
TBD
Trial ID
NCT02065765
Treatments Being Tested
Participants will receive study treatment with agenT-797, botensilimab, bal...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2024-02-01
Trial ID
NCT06251973
Treatments Being Tested
This is a multicenter Phase 1b, open-label study to assess safety, tolerabi...
Status
Active Not Recruiting
Location
Exelixis Clinical Site #53
Start Date
2017-09-05
Trial ID
NCT03170960
Treatments Being Tested
This phase Ib trial studies the side effects of nivolumab and to see how we...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-07-16
Trial ID
NCT03816345
BACKGROUND: Gastric cancer is one of the most common cancers and is one of ...
Status
Terminated
Location
AC Camargo Cancer Center
Start Date
2020-01-01
Trial ID
NCT04168931
Treatments Being Tested
This multi-site, Phase 1/2 clinical trial is an open-label study to identif...
Status
Recruiting
Location
Precision NextGen Oncology
Start Date
2023-11-01
Trial ID
NCT06047379
A Phase 2, multi-center, open-label study of cinrebafusp alfa (PRS-343) in ...
Status
Active Not Recruiting
Location
Sansum Clinic
Start Date
2021-11-01
Trial ID
NCT05190445
The purpose of this study is to evaluate progression-free survival in parti...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2013-12
Trial ID
NCT01983878
Treatments Being Tested